Additionally, the TREAT-AD (TaRget Enablement to Accelerate Therapy development for Alzheimer’s Disease) Center has identified MDA5, LGP2, and DDX1 as potential risk factors in Alzheimer’s disease progression 22. This evidence concerns the gene IFIH1 and Alzheimer disease.